UBS AM’s RxSight RXST Stock Holding History

UBS AM’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$397K	Hold	64,510	–	–	﹤0.01%	2598
2025 Q4	$672K	Hold	64,510	–	–	﹤0.01%	2259
2025 Q3	$580K	Sell	64,510 -144,153	-69%	-$1.27M	﹤0.01%	2135
2025 Q2	$2.71M	Buy	208,663 +115,281	+123%	+$1.73M	﹤0.01%	2006
2025 Q1	$2.36M	Buy	93,382 +8,424	+10%	+$250K	﹤0.01%	1913
2024 Q4	$2.92M	Buy	84,958 +16,140	+23%	+$728K	﹤0.01%	1866
2024 Q3	$3.4M	Buy	68,818 +5,266	+8%	+$270K	﹤0.01%	1770
2024 Q2	$3.82M	Buy	63,552 +32,729	+106%	+$1.87M	﹤0.01%	1640
2024 Q1	$1.59M	Buy	30,823 +1,900	+7%	+$93.3K	﹤0.01%	1787
2023 Q4	$1.17M	Buy	28,923 +17,235	+147%	+$506K	﹤0.01%	1947
2023 Q3	$326K	Buy	+11,688	New	+$348K	﹤0.01%	2411

Other funds holding RXST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS AM's RXST Position: Q1 2026 in Review

UBS AM held its RxSight (RXST) position steady in Q1 2026 at 64,510 shares worth $397K. The position accounts for ﹤0.01% of the portfolio, ranked #2598.

UBS AM first reported a position in RXST in Q3 2023 and has held it in 11 quarters since. The position peaked at $3.82M in Q2 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

UBS AM held 64,510 shares of RxSight worth $397K as of Q1 2026.
UBS AM left its RxSight share count unchanged in Q1 2026.
RxSight made up ﹤0.01% of UBS AM's portfolio in Q1 2026, its #2598 holding.
UBS AM first reported a position in RxSight in Q3 2023 and has held it in 11 quarters since.
UBS AM's RxSight position peaked at $3.82M in Q2 2024.
164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.